SAUCEDO JOSEPH R 4

4 · ICU MEDICAL INC/DE · Filed Oct 10, 2017

Insider Transaction Report

Form 4

Period: 2017-10-09

ICU MEDICAL INC/DEICUI

SAUCEDO JOSEPH R

Director

Transactions

Sale
Common Stock
2017-10-09$189.49/sh−4,600$871,640→ 3,291 total
Exercise of In-Money
Common Stock
2017-10-09$33.52/sh+1,500$50,280→ 6,091 total
Exercise of In-Money
Common Stock
2017-10-09$43.12/sh+1,500$64,680→ 9,091 total
Exercise of In-Money
Common Stock
2017-10-09$39.38/sh+1,500$59,070→ 12,091 total
Sale
Common Stock
2017-10-09$189.01/sh−600$113,408→ 11,491 total
Sale
Common Stock
2017-10-09$190.67/sh−300$57,200→ 9,091 total
Sale
Common Stock
2017-10-09$189.00/sh−1,200$226,800→ 7,891 total
Sale
Common Stock
2017-10-09$190.85/sh−200$38,170→ 3,091 total
Exercise of In-Money
Common Stock
2017-10-09$32.40/sh+1,500$48,600→ 4,591 total
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2017-10-09$33.52/sh−1,500$50,280→ 0 total
Exercise: $33.52From: 2011-04-21Exp: 2020-04-21→ Common Stock (1,500 underlying)
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2017-10-09$39.38/sh−1,500$59,070→ 0 total
Exercise: $39.38From: 2012-10-19Exp: 2021-10-19→ Common Stock (1,500 underlying)
Exercise of In-Money
Common Stock
2017-10-09$37.00/sh+1,500$55,500→ 7,591 total
Exercise of In-Money
Common Stock
2017-10-09$36.60/sh+1,500$54,900→ 10,591 total
Sale
Common Stock
2017-10-09$189.48/sh−2,100$397,913→ 9,391 total
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2017-10-09$32.40/sh−1,500$48,600→ 0 total
Exercise: $32.40From: 2011-02-03Exp: 2020-02-03→ Common Stock (1,500 underlying)
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2017-10-09$36.60/sh−1,500$54,900→ 0 total
Exercise: $36.60From: 2011-10-20Exp: 2020-10-20→ Common Stock (1,500 underlying)
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2017-10-09$37.00/sh−1,500$55,500→ 0 total
Exercise: $37.00From: 2011-07-21Exp: 2020-07-21→ Common Stock (1,500 underlying)
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2017-10-09$43.12/sh−1,500$64,680→ 0 total
Exercise: $43.12From: 2012-02-02Exp: 2021-02-02→ Common Stock (1,500 underlying)

Footnotes (7)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.25 to $189.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.25 to $190.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.40 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.20 to $189.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.20 to $190.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.70 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT